financetom
Business
financetom
/
Business
/
Jaguar Mining Posts Lower Q4 Net Income YOY
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Jaguar Mining Posts Lower Q4 Net Income YOY
Mar 26, 2024 4:10 AM

06:47 AM EDT, 03/26/2024 (MT Newswires) -- Jaguar Mining Inc. ( JAGGF ) reported overnight Monday a fourth-quarter 2023 net income of US$10.7 million, or US$0.14 per share, down from US$11.5 million, or US$0.16 per share, in the year-ago quarter.

Revenue came in at US$35.9 million, down from US$36.1 million in the year-ago quarter. The decrease was driven by fewer ounces produced and sold, offset by higher realized gold prices.

Adjusted EBITDA was US$10.8 million, or US$0.14 per share, down from US$11.0 million, or US$0.15 per share, in the prior-year period.

Jaguar produced 18,482 ounces of gold in the fourth quarter of 2023, a decrease from 21,116 ounces of gold a year ago.

In 2024, the company expects production levels at the Turmalina and Pilar mines to be consistent with the fourth quarter of 2023. Faina is expected to contribute to production in the second half of the year, resulting in higher overall production from 2023 levels.

Jaguar lost 2.6% yesterday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lisata Therapeutics Receives European Medicines Agency Pediatric Waiver for Pancreatic Cancer Treatment
Lisata Therapeutics Receives European Medicines Agency Pediatric Waiver for Pancreatic Cancer Treatment
May 20, 2024
11:14 AM EDT, 05/20/2024 (MT Newswires) -- Lisata Therapeutics ( LSTA ) said Monday it has obtained a full pediatric waiver from the European Medicines Agency for investigational drug certepetide in pancreatic cancer. The agency granted the waiver based on the recommendation of its pediatric committee, which cited that pancreatic cancer occurs exclusively in adults, the company said. The waiver...
Jeffs' Brands Signs Memorandum of Understanding to Buy New Jersey Logistics Center Operator; Shares Fall
Jeffs' Brands Signs Memorandum of Understanding to Buy New Jersey Logistics Center Operator; Shares Fall
May 20, 2024
11:06 AM EDT, 05/20/2024 (MT Newswires) -- Jeffs' Brands ( JFBR ) said Monday it has signed a Memorandum of Understanding to acquire a company that operates a logistics center in New Jersey. The potential acquisition encompasses a logistics center covering about 100,000 square feet with 20 loading docks, the company said. Jeffs' Brands ( JFBR ) shares were down...
Foghorn Therapeutics Prices $110 Million Offering of Shares, Pre-Funded Warrants
Foghorn Therapeutics Prices $110 Million Offering of Shares, Pre-Funded Warrants
May 20, 2024
11:14 AM EDT, 05/20/2024 (MT Newswires) -- Foghorn Therapeutics ( FHTX ) said Monday it priced a registered direct offering of 12.7 million shares at $5.51 each, along with pre-funded warrants to buy up to 7.2 million shares at $5.5099 apiece in lieu of stock to certain investors, for gross proceeds of $110 million. The offering is expected to close...
SouthState Agrees to Buy Independent Bank Group in $2 Billion All-Stock Transaction
SouthState Agrees to Buy Independent Bank Group in $2 Billion All-Stock Transaction
May 20, 2024
11:14 AM EDT, 05/20/2024 (MT Newswires) -- Southeast regional bank SouthState ( SSB ) agreed to buy Independent Bank Group ( IBTX ) in a $2 billion all-stock deal, expanding its presence into Texas and Colorado. Shareholders of Independent Bank Group ( IBTX ) will receive 0.60 shares of SouthState ( SSB ) common stock for each share owned, according...
Copyright 2023-2026 - www.financetom.com All Rights Reserved